rad ai vs Andson Biotech

Side-by-side comparison of AI visibility scores, market position, and capabilities

Andson Biotech leads in AI visibility (41 vs 35)
rad ai logo

rad ai

EmergingMarketing

General

Los Angeles AI marketing intelligence platform (rebranded RAD AI→RAD Intel Nov 2024); $27M raised at $85M valuation with 2025 contracted revenue doubling on influencer ROI engine competing with CreatorIQ for creator economy analytics.

AI VisibilityBeta
Overall Score
D35
Category Rank
#630 of 1158
AI Consensus
52%
Trend
up
Per Platform
ChatGPT
28
Perplexity
37
Gemini
41

About

RAD Intel (formerly RAD AI until November 2024) is a Los Angeles, California-based AI-powered marketing intelligence platform — having raised approximately $27 million from over 6,500 investors, VCs, and executives from Google, Amazon, and Meta at an $85 million valuation — providing brands and agencies with ROI-based creative intelligence for influencer marketing, content strategy, and campaign optimization using proprietary AI persona engines that analyze real internet conversations to deliver unbiased, data-driven recommendations. Founded in 2018 by CEO Jeremy Barnett (three-time entrepreneur), RAD Intel's name stands for "Remove All Doubt" — reflecting its mission to eliminate guesswork from marketing decisions. In 2021, RAD Intel acquired Atomic Reach (a $27 million R&D investment in AI content optimization), bringing co-founder Bradley Silver (former Atomic Reach CEO) as President to lead product development and operations. RAD Intel rebranded from RAD AI to RAD Intel in November 2024 to better reflect its intelligence-first positioning. In 2025, contracted revenue is projected to double that of 2024, targeting the $633 billion creator economy.

Full profile
Andson Biotech logo

Andson Biotech

EmergingHealthcare

General

Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.

AI VisibilityBeta
Overall Score
C41
Category Rank
#220 of 1158
AI Consensus
62%
Trend
up
Per Platform
ChatGPT
49
Perplexity
36
Gemini
40

About

Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.

Full profile

AI Visibility Head-to-Head

35
Overall Score
41
#630
Category Rank
#220
52
AI Consensus
62
up
Trend
up
28
ChatGPT
49
37
Perplexity
36
41
Gemini
40
44
Claude
41
26
Grok
51

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.